IDSA recommends shorter antibiotic courses for adults with cUTIs who show clinical improvement on effective therapy.
ATLANTA, GA - October 29, 2025 (NEWMEDIAWIRE) - GeoVax Labs, Inc. (Nasdaq: GOVX), a clinical-stage biotechnology company developing multi-antigen vaccines and immunotherapies, today emphasized how its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results